DBVT DBV Technologies S.A.
Healthcare$18.18-2.10%ClosedMarket Cap: $434.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
7.98
P/S
0.00
EV/EBITDA
-2.73
DCF Value
$1.72
FCF Yield
-23.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-130.1%
ROA
-63.0%
ROIC
-74.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-47.9M | $-47.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-45.1M | $-44.8M | $— | — |
| FY null | $0.00 | NaN% | $-147.1M | $-146.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-36.9M | $-33.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-43.1M | $-42.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-26.6M | $-27.1M | $— | — |
| Q4 null | $511.0K | 100.0% | $-23.9M | $-23.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-120.5M | $-113.7M | $— | — |
| Q3 null | $1.1M | 100.0% | $-30.3M | $-30.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-35.0M | $-33.1M | $— | — |
| Q1 null | $1.4M | 100.0% | $-28.6M | $-27.3M | $— | — |
| Q4 2023 | $8.9M | 100.0% | $-11.9M | $-11.2M | $-0.60 | — |